TRIB3 and metabolic syndrome: First, there were no statistically significant differences in body weight, blood glucose, total plasma cholesterol, plasma triglycerides, and peripheral blood cell counts between the 2 groups of mice (Figure S7A through S7E), indicating that loss of TRIB3 in hematopoietic cells does not result in major metabolic or cellular perturbations under conditions of atherogenic dyslipidemia.